{"id":"kwedl","name":"rosecap","short_name":"Rose Capital","start_url":"/pwa/","theme_color":"#ffffff","display":"standalone","background_color":"#c4c4c4","description":" \nRose Capital believe that the rising global demand for healthcare products and services will continue to create attractive opportunities. We look to acquire or invest into businesses with strong management teams, stable cash flows and robust growth prospects. \nDeal size is a minimum of £50m up to £300m. Our creative structuring and financing solutions allow us to maintain flexibility with respect to deal structure, and we utilise a prudent approach to leverage. Operating Executives and Advisors are an integral part of our team, providing strategic insight, operational oversight, and senior counsel that help drive growth and performance to create long-term value and sustainable businesses.\n ","icons":[{"src":"https://cdn.fanstad.com/media/thumb/539ccd5f-445c-.png","sizes":"192x192","type":"image/png"},{"src":"https://cdn.fanstad.com/media/thumb/539ccd5f-445c-.png","sizes":"512x512","type":"image/png"}]}